Skip to main content
. 2021 Mar 20;13(1):157–163. doi: 10.1007/s13193-021-01309-5

Table 2.

Comparative significance of clinicopathological and survival variables

Variable PDA PDC P value
Age (in years) 51 ± 12 54 ± 10.5 0.114
Sex ratio (M:F) 1:1.3 1:1.6 0.621
Lymphadenopathy 50% 55% 0.807
Tumour size (in cm) 4.6 ± 0.9 4.9 ± 1.2 0.09
ETI 59% 73% 0.03
Metastasis 14% 41% 0.009
Recurrence rate 25% 46% 0.02
5 year RFS 90% 42% 0.09
5 year OS 93% 44% 0.008